ResearcherSecond Military Medical UniversityActive in the last 2 years
Gang Jin
Matched on ORCID iD 0000-0003-3655-2934; OpenAlex author ID A5084037694. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 22
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreatic cancer. Co-author DOI 10.1007/s00259-025-07491-w↗
- Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET/MR versus [18F]-FDG PET/CT plus contrast-enhanced CT: a prospective preliminary stu… Co-author DOI 10.1007/s00259-024-06943-z↗
- A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.tranon.2025.102282↗
- Integrated 68 Ga-FAPI-04 PET/MR in Pancreatic Cancer : Prediction of Tumor Response and Tumor Resectability After Neoadjuvant Therapy. Co-author DOI 10.1097/rlu.0000000000005300↗
- Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. Last author DOI 10.1016/j.ijsu.2022.106786↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiwei Guo · 5 shared papers, 2022–2026 · strength 1.08
- Paper Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreati… DOI 10.1007/s00259-025-07491-w↗
- Paper Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET/MR versus [18F]-FDG PET/CT plus contrast-en… DOI 10.1007/s00259-024-06943-z↗
- Paper Integrated 68 Ga-FAPI-04 PET/MR in Pancreatic Cancer : Prediction of Tumor Response and Tumor Resectability After Neoad… DOI 10.1097/rlu.0000000000005300↗
- Changjing Zuo · 3 shared papers, 2024–2026 · strength 0.75
- Paper Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreati… DOI 10.1007/s00259-025-07491-w↗
- Paper Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET/MR versus [18F]-FDG PET/CT plus contrast-en… DOI 10.1007/s00259-024-06943-z↗
- Paper Integrated 68 Ga-FAPI-04 PET/MR in Pancreatic Cancer : Prediction of Tumor Response and Tumor Resectability After Neoad… DOI 10.1097/rlu.0000000000005300↗
- Chao Cheng · 3 shared papers, 2024–2026 · strength 0.75
- Paper Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreati… DOI 10.1007/s00259-025-07491-w↗
- Paper Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET/MR versus [18F]-FDG PET/CT plus contrast-en… DOI 10.1007/s00259-024-06943-z↗
- Paper Integrated 68 Ga-FAPI-04 PET/MR in Pancreatic Cancer : Prediction of Tumor Response and Tumor Resectability After Neoad… DOI 10.1097/rlu.0000000000005300↗
- Zeyu Zhang · 2 shared papers, 2025–2026 · strength 0.51
- Paper Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreati… DOI 10.1007/s00259-025-07491-w↗
- Paper Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET/MR versus [18F]-FDG PET/CT plus contrast-en… DOI 10.1007/s00259-024-06943-z↗
- Weiwei Su · 2 shared papers, 2025–2026 · strength 0.51
- Paper Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreati… DOI 10.1007/s00259-025-07491-w↗
- Paper Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET/MR versus [18F]-FDG PET/CT plus contrast-en… DOI 10.1007/s00259-024-06943-z↗
- Suizhi Gao · 2 shared papers, 2022–2025 · strength 0.33
- Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Kailian Zheng · 2 shared papers, 2022–2025 · strength 0.33
- Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Guoxiao Zhang · 2 shared papers, 2022–2025 · strength 0.33
- Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Xiaoyi Yin · 2 shared papers, 2022–2025 · strength 0.33
- Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Xiaohan Shi · 2 shared papers, 2022–2025 · strength 0.33
- Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Haojun Chen · 1 shared paper, 2026 · strength 0.26
- Yu-Chao Li · 1 shared paper, 2026 · strength 0.26
- Kai Cao · 1 shared paper, 2024 · strength 0.24
- Zeyu Zhang · 1 shared paper, 2024 · strength 0.24
- Xiongfei Xu · 1 shared paper, 2025 · strength 0.20
- Bo Li · 1 shared paper, 2025 · strength 0.20
- Meilong Shi · 1 shared paper, 2025 · strength 0.20
- Xiangui Hu · 1 shared paper, 2022 · strength 0.13
- Shuo Shen · 1 shared paper, 2022 · strength 0.13
- Bo Li · 1 shared paper, 2022 · strength 0.13
- Gang Li · 1 shared paper, 2022 · strength 0.13
- Tianlin He · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.